Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine + Capecitabine vs Gemcitabine in Advanced Pancreatic Cancer
NCT00030732Phase 3Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Jun 2001
- Primary completion
- Jun 2004
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of capecitabine in pancreatic cancer (PC), sponsored by Swiss Group for Clinical Cancer Research. Started Jun 2001; status: completed.
02
Drugs
capecitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00030732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00030732.